Kratom Litigation: What Drives Juror Decisions, Part 2 – The Three Pillars of Fault
Published on February 19, 2025 by Dr. Juli Adelman
Building on our analysis of the first U.S. kratom verdict, which resulted in a $2.5 million award, this article explores the key factors that jurors consider when assigning fault in kratom litigation: (1) the user of the product, (2) the manufacturer/supplier, and (3) warnings and labeling.
The User of the Product
Jurors rigorously scrutinize a plaintiff’s credibility and choices. While some may question why a plaintiff used kratom, it is often sought as an alternative treatment. However, jurors tend to be skeptical of self-medication with an FDA-unapproved product.
Key questions jurors consider:
- Did the plaintiff pursue safer alternatives (e.g., medical care, physical therapy) before turning to kratom?
- Was the plaintiff’s age or education level a factor in their ability to assess risks?
- Was kratom used to replace another addiction?
- Did the plaintiff have preexisting health conditions?
Understanding how jurors judge alternative medicine use is critical for developing case strategy.
The Suppliers and Manufacturers
Jurors demand transparency in product safety, particularly in the kratom industry where supply chains are often obscured. The kratom industry has expanded significantly, using multiple layers of LLCs and mislabeling shipments to pass customs.
Key concerns for jurors:
- Who is the supplier and manufacturer? Jurors dislike companies that hide their identities through shell corporations.
- How is the product tested for safety? The FDA has issued alerts allowing inspectors to confiscate kratom products, yet many suppliers sidestep regulations by mislabeling shipments.
Jurors will closely examine whether manufacturers tested products for bacteria, heavy metals, purity, and alkaloid content before selling them in the U.S.
Warnings and Labels
Kratom is sold in various forms—energy shots, pills, and tea—at gas stations, vape shops, and online. However, labeling is often unclear, leading users to seek guidance from alternative sources like online forums and books.
Jurors’ attitudes toward warning labels vary:
- Some take a literal approach, scrutinizing labels word for word.
- Others rely on common sense or general knowledge.
Regardless of interpretation, product labeling—especially misleading claims—will be a key issue in litigation.
Strategic Takeaways for Kratom Litigation
- Anticipate juror biases: If a plaintiff lacks credibility, focus on the manufacturer’s failures in ensuring product safety.
- The jury will hold someone accountable: Defendants using shell corporations to evade liability should be prepared to justify their business practices.
- Warning and Labels: Voir dire strategies should identify jurors with favorable views on warning labels.
By applying pharmaceutical liability frameworks to kratom cases, attorneys can proactively shape juror expectations and minimize surprises during trial.
Download PDF